NM_001364905.1:c.7937T>G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001364905.1(LRBA):c.7937T>G(p.Ile2646Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,460,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001364905.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRBA | NM_001364905.1 | c.7937T>G | p.Ile2646Ser | missense_variant | Exon 53 of 57 | ENST00000651943.2 | NP_001351834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRBA | ENST00000651943.2 | c.7937T>G | p.Ile2646Ser | missense_variant | Exon 53 of 57 | NM_001364905.1 | ENSP00000498582.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460970Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726788
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Combined immunodeficiency due to LRBA deficiency Pathogenic:3
The variant c.7970T>G (p.Ile2657Ser) in LRBA gene has been previously reported in individuals with early-onset immune deficiency and autoimmunity (LopezHerrera G et al, Revel-Vilk S et al). This variant has been reported to the ClinVar database as Pathogenic. The amino acid Ile at position 2657 is changed to a Ser changing protein sequence and it might alter its composition and physico-chemical properties. This sequence change replaces isoleucine with serine at codon 2657 of the LRBA protein (p.Ile2657Ser). The isoleucine residue is moderately conserved and there is a large physicochemical difference between isoleucine and serine. The residue is conserved across species. The variant is predicted to be damaging by both SIFT and PolyPhen2. The amino acid change p.Ile2657Ser in LRBA is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The p.Ile2657Ser variant is novel (not in any individuals) in gnomAD Exomes and 1000 Genomes. For these reasons, this variant has been classified as pathogenic. -
This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2657 of the LRBA protein (p.Ile2657Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early-onset immune deficiency and autoimmunity (PMID: 22608502, 25931386, 28197149). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as c.7937T>G: p.I2646S. ClinVar contains an entry for this variant (Variation ID: 35455). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt LRBA protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects LRBA function (PMID: 22608502, 25931386). For these reasons, this variant has been classified as Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at